Basit öğe kaydını göster

dc.contributor.authorÇatıkkaş, Nezahat Müge
dc.contributor.authorBahat-Öztürk, Gülistan
dc.contributor.authorKaran, Mehmet Akif
dc.contributor.authorPetrovic, Mirko
dc.date.accessioned2021-12-10T10:56:52Z
dc.date.available2021-12-10T10:56:52Z
dc.identifier.citationÇatıkkaş N. M. , Bahat-Öztürk G., Karan M. A. , Petrovic M., "State of the art while managing diabetes in older adults: eight case studies with focus on sglt-2 inhibitors and metformin", 2021 ESPEN Virtual, 9 - 14 Eylül 2021, cilt.46, ss.743
dc.identifier.othervv_1032021
dc.identifier.otherav_5dcbef22-7f43-481b-bfcc-74b144d6fb0d
dc.identifier.urihttp://hdl.handle.net/20.500.12627/170897
dc.identifier.urihttps://doi.org/10.1016/j.clnesp.2021.09.562
dc.identifier.urihttps://clinicalnutritionespen.com/article/S2405-4577(21)00885-8/fulltext
dc.description.abstractRationale:Sodium-glucose co-transporter-2 (SGLT-2) inhibitors have been recently introduced for type 2 diabetes treatment with significant cardiovascular, renal benefits. Yet, they have frequently been refrained in older adults. Metformin is regarded the firstline diabetes therapy in all ages; still it is associated with weight loss and frailty in older adults. We aimed to outline our experience with three oldest-old patients with high cardiovascular risk managed with SGLT-2 inhibitors, and five patients with anorexia/weight loss managed by metformin cessation.
dc.language.isoeng
dc.subjectİç Hastalıkları
dc.subjectGeriatri
dc.subjectFamily Practice
dc.subjectGeriatrics and Gerontology
dc.subjectFundamentals and Skills
dc.subjectGeneral Health Professions
dc.subjectPathophysiology
dc.subjectInternal Medicine
dc.subjectAssessment and Diagnosis
dc.subjectMedicine (miscellaneous)
dc.subjectGeneral Medicine
dc.subjectSağlık Bilimleri
dc.subjectTıp
dc.subjectHealth Sciences
dc.subjectDahili Tıp Bilimleri
dc.subjectTIP, GENEL & İÇECEK
dc.subjectGERİATRİK VE GERONTOLOJİ
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.titleState of the art while managing diabetes in older adults: eight case studies with focus on sglt-2 inhibitors and metformin
dc.typeBildiri
dc.contributor.departmentİstanbul Üniversitesi , İstanbul Tıp Fakültesi , Dahili Tıp Bilimleri Bölümü
dc.identifier.volume46
dc.contributor.firstauthorID2771898


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster